Last update 19 Apr 2025

Trastuzumab biosimilar (BioXpress Therapeutics)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
Trastuzumab Biosimilar (BioXpress Therapeutics SA), 曲妥珠单抗生物类似药（BioXpress Therapeutics SA）, BX-2318
+ [1]
Target
HER2
Action
antagonists
Mechanism
HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal DiseasesDigestive System Disorders
Active Indication
Metastatic breast cancerMetastatic Gastric Carcinoma
Inactive Indication-
Originator Organization
BioXpress Therapeutics SABioXpress Therapeutics SA
Active Organization
BioXpress Therapeutics SABioXpress Therapeutics SA
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Related

100 Clinical Results associated with Trastuzumab biosimilar (BioXpress Therapeutics)
Login to view more data
100 Translational Medicine associated with Trastuzumab biosimilar (BioXpress Therapeutics)
Login to view more data
100 Patents (Medical) associated with Trastuzumab biosimilar (BioXpress Therapeutics)
Login to view more data
100 Deals associated with Trastuzumab biosimilar (BioXpress Therapeutics)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
L01XC03
DB00072

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic breast cancerPreclinical
Switzerland
BioXpress Therapeutics SABioXpress Therapeutics SA
13 Mar 2024
Metastatic Gastric CarcinomaPreclinical
Switzerland
BioXpress Therapeutics SABioXpress Therapeutics SA
20 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free